The U.S. Centers for Disease Control and Prevention have recommended the first-ever vaccine designed to protect infants from respiratory syncytial virus. The CDC said the Pfizer vaccine should be taken during weeks 32 and 36 of pregnancy.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
US CDC panel weighs use of Pfizer's maternal RSV vaccine to protect infantsA panel of advisers to the U.S. Centers for Disease Control and Prevention (CDC) on Friday will vote on the use of Pfizer's respiratory syncytial virus (RSV) vaccine in pregnant women, likely paving the way for it to become the country's first maternal shot for protecting babies from the virus.
Consulte Mais informação »
Pfizer maternal RSV vaccine recommended by CDC advisorsA Centers for Disease Control and Prevention advisory committee on Friday recommended pregnant people get Pfizer Inc.’s maternal vaccine to protect babies...
Consulte Mais informação »
CDC advisors recommend Pfizer maternal RSV vaccine to protect infantsCDC Director Mandy Cohen still needs to sign off on that recommendation before mothers can receive Pfizer’s shot to protect their infants from RSV.
Consulte Mais informação »
CDC committee recommends RSV vaccine given to pregnant people to protect their babiesThe vaccine is the first of its kind to be approved. It can shield infants from respiratory syncytial virus during their first 6 months.
Consulte Mais informação »
Pfizer maternal RSV vaccine recommended by CDC advisersNew shot aims to protect babies from a leading cause of hospitalization.
Consulte Mais informação »
CDC panel recommends Pfizer maternal RSV vaccine to protect babiesAn independent panel of independent advisers for the Centers for Disease Control and Prevention backed Pfizer's respiratory syncytial virus, or RSV, vaccine for pregnant women to confer immunity to newborns on Friday.
Consulte Mais informação »